Optimal use of ??-blockers in high-risk hypertension: A guide to dosing equivalence

McGill J ...see all

Vascular Health and Risk Management, vol. 6, issue 1 (2010) pp. 363-372

  • 38


    Mendeley users who have this article in their library.
  • Citations

    Citations of this article.
Sign in to save reference


Hypertension is the number one diagnosis made by primary care physicians, placing them in a unique position to prescribe the antihypertensive agent best suited to the individual patient. In individuals with diabetes mellitus, blood pressure (BP) levels>130/80 mmHg confer an even higher risk for cardiovascular and renal disease, and these patients will benefit from aggressive antihypertensive treatment using a combination of agents. beta-blockers are playing an increasingly important role in the management of hypertension in high-risk patients. beta-blockers are a heterogeneous class of agents, and this review presents the differences between beta-blockers and provides evidence-based protocols to assist in understanding dose equivalence in the selection of an optimal regimen in patients with complex needs. The clinical benefits provided by beta-blockers are only effective if patients adhere to medication treatment long term. beta-blockers with proven efficacy, once-daily dosing, and lower side effect profiles may become instrumental in the treatment of hypertensive diabetic and nondiabetic patients.

Author-supplied keywords

  • Antihypertensive
  • Atenolol
  • Blood pressure
  • Carvedilol
  • Labetalol
  • Metoprolol
  • Nebivolol

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free